Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Breast (Edinburgh, Scotland)|June 5, 2004
Screening-detected breast carcinoma in a patient with Cowden syndromeM G Baù, R Arisio, G Cristini, et al.Cardiologia (Rome, Italy)|June 1, 1990
[Evaluation of complications during laser angioplasty with a hot tip system in the treatment of peripheral arteriopathy]E Barbieri, A Perbellini, G Taddei, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 14, 2021
Oncophone20 study: Patients' perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancersElisa Picardo, Maria G Baù, Caterina Anatrone, et al.La Radiologia Medica|March 1, 1993
[Diagnostic imaging in non-palpable breast lesions. Targeted++ ultrasonography versus direct radiologic magnification]P Burke, M R Di Virgilio, E Luparia, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|October 24, 2015
β-thalassemia patients and gynecological approach: review and clinical experienceSimona Ambroggio, Clementina Peris, Elisa Picardo, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 13, 2015
The first case of breast cancer in thalassemic patient: case report and review of literatureE Picardo, M Mitidieri, E Minniti, et al.Cancer Chemotherapy and Pharmacology|March 6, 1998
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot studyL Dogliotti, S Danese, A Berruti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trialL Dogliotti, A Berruti, T Buniva, et al.Anticancer Research|July 1, 1997
Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survivalA Berruti, P Zola, T Buniva, et al.Pageof 1